Thromboelastography reflects global hemostatic variation among severe haemophilia A dogs at rest and following acute exercise

Haemophilia

Volumn 15, Issue 5, 2009, Pages 1126-1134

  Othman, M ^a   Powell, S ^a   Chirinian, Y ^a   Hegadorn, C ^a   Hopman, W ^b   Lillicrap, D ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

Exercise; Hemophilia A dogs; TEG

Indexed keywords

BLOOD CLOTTING FACTOR 8;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; BLOOD CELL COUNT; BLOOD CLOTTING TIME; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE SEVERITY; DOG; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM CELL; EXERCISE; FEMALE; HEMOPHILIA A; HEMOSTASIS; MALE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY;

ANIMALS; BLOOD COAGULATION; DOG DISEASES; DOGS; FACTOR VIII; FEMALE; HEMOPHILIA A; HEMOSTASIS; HEMOSTATICS; MALE; PHYSICAL CONDITIONING, ANIMAL; REST; THROMBELASTOGRAPHY;

EID: 69949102119     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2009.02037.x     Document Type: Article

References (28)

1. Hartert H. [Thrombelastography, a method for physical analysis of blood coagulation.]. Z Gesamte Exp Med 1951; 117: 189-203.
2. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005; 27: 81-90.
3. Young G, Blain R, Nakagawa P, Nugent DJ. Individualization of bypassing agent treatment for haemophilic patients with inhibitors utilizing thromboelastography. Haemophilia 2006; 12: 598-604.
4. Ghosh K, Shetty S, Kulkarni B. Correlation of thromboelastographic patterns with clinical presentation and rationale for use of antifibrinolytics in severe haemophilia patients. Haemophilia 2007; 13: 734-9.
5. Prasad S, Lillicrap D, Labelle A et al. Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A. Blood 2008; 111: 672-9.
6. Giles AR, Tinlin S, Hoogendoorn H, Fournel MA, Ng P, Pancham N. In vivo characterization of recombinant factor VIII in a canine model of hemophilia A (factor VIII deficiency). Blood 1988; 72: 335-9.
7. Hough C, Kamisue S, Cameron C et al. Aberrant splicing and premature termination of transcription of the FVIII gene as a cause of severe canine hemophilia A: Similarities with the intron 22 inversion mutation in human hemophilia. Thromb Haemost 2002; 87: 659-65.
8. Scallan CD, Lillicrap D, Jiang H et al. Sustained phenotypic correction of canine hemophilia A using an adeno-associated viral vector. Blood 2003; 102: 2031-7.
9. Brown BD, Shi CX, Powell S, Hurlbut D, Graham FL, Lillicrap D. Helper-dependent adenoviral vectors mediate therapeutic factor VIII expression for several months with minimal accompanying toxicity in a canine model of severe hemophilia A. Blood 2004; 103: 804-10.
10. Budde U, Schneppenheim R, Plendl H, Dent J, Ruggeri ZM, Zimmerman TS. Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes. Thromb Haemost 1990; 63: 312-5.
11. Othman M, Labelle A, Mazzetti I, Elbatarny HS, Lillicrap D. Adenovirus-induced thrombocytopenia: The role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance. Blood 2007; 109: 2832-9.
12. Schneiderman J, Rubin E, Nugent DJ, Young G. Sequential therapy with activated prothrombin complex concentrates and recombinant FVIIa in patients with severe haemophilia and inhibitors: Update of our previous experience. Haemophilia 2007; 13: 244-8.
13. Hayashi T, Tanaka I, Shima M et al. Unresponsiveness to factor VIII inhibitor bypassing agents during haemostatic treatment for life-threatening massive bleeding in a patient with haemophilia A and a high responding inhibitor. Haemophilia 2004; 10: 397-400.
14. Sorensen B, Ingerslev J. Thromboelastography and recombinant factor VIIa-hemophilia and beyond. Semin Hematol 2004; 41: 140-4.
15. Sorensen B, Johansen P, Christiansen K, Woelke M, Ingerslev J. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003; 1: 551-8.
16. Fenger-Eriksen C, Anker-Moller E, Heslop J, Ingerslev J, Sorensen B. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: Improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anaesth 2005; 94: 324-9.
17. van den Berg HM, De Groot PH, Fischer K. Phenotypic heterogeneity in severe hemophilia. J Thromb Haemost 2007; 5 (Suppl. 1): 151-6.
18. Poller L, Priest CM, Thomson JM. Platelet aggregation and strenuous exercise. J Physiol 1971; 213: 525-31.
19. Smith JE. Effects of strenuous exercise on haemostasis. Br J Sports Med 2003; 37: 433-5.
20. Smith JE, Garbutt G, Lopes P, Pedoe DT. Effects of prolonged strenuous exercise (marathon running) on biochemical and haematological markers used in the investigation of patients in the emergency department. Br J Sports Med 2004; 38: 292-4.
21. Hawkey CM, Britton BJ, Wood WG, Peele M, Irving MH. Changes in blood catecholamine levels and blood coagulation and fibrinolytic activity in response to graded exercise in man. Br J Haematol 1975; 29: 377-84.
22. Rock G, Tittley P, Pipe A. Coagulation factor changes following endurance exercise. Clin J Sport Med 1997; 7: 94-9.
23. Bartsch P, Welsch B, Albert M, Friedmann B, Levi M, Kruithof EK. Balanced activation of coagulation and fibrinolysis after a 2-h triathlon. Med Sci Sports Exerc 1995; 27: 1465-70.
24. Moesgaard SG, Holte AV, Mogensen T et al. Effects of breed, gender, exercise and white-coat effect on markers of endothelial function in dogs. Res Vet Sci 2007; 82: 409-15.
25. Ribeiro JL, Salton GD, Bandinelli E, Oliveira AR, Roisenberg I. The effect of ABO blood group on von Willebrand response to exercise. Clin Appl Thromb Hemost 2007; 14: 454-8.
26. Stakiw J, Bowman M, Hegadorn C et al. The effect of exercise on von Willebrand factor and ADAMTS-13 in individuals with type 1 and type 2B von Willebrand disease. J Thromb Haemost 2008; 6: 90-6.
27. Balen S, Ruzic A, Mirat J, Persic V. Exercise induced von Willebrand Factor release -new model for routine endothelial testing. Med Hypotheses 2007; 69: 1320-2.
28. Tschakovsky ME. Introduction to proceedings from the 2005 CSEP symposium "Exercise and the endothelium". Appl Physiol Nutr Metab 2008; 33: 149-50.